Share this article
Share this article
ALAMEDA, Calif., April 27, 2021 /PRNewswire/ Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.
Event: BofA Securities 2021 Virtual Health Care Conference
Date: Tuesday, May 11, 2021
Time: 11:45am ET / 8:45am PT
A webcast of the presentation will be available by visiting the investors section of the company s website at www.penumbrainc.com. The webcast will be available on the company s website for at least two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals
Eargo to Present at BofA Securities 2021 Virtual Health Care Conference benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference
BOSTON, April 07, 2021 (GLOBE NEWSWIRE) Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in a fireside chat at the 20
th Annual Needham & Co. Virtual Healthcare Conference on Wednesday, April 14, 2021 at 11:45 a.m. ET.
A live audio webcast of the presentation will be available under Events & Presentations in the Investor Relations section of the Company s website at www.rhythmtx.com. A replay of the webcast will be available on the Rhythm website for 30 days following each presentation.
Enterome to Present at Upcoming Conferences
News provided by
Share this article
PARIS, April 7, 2021 /PRNewswire/
ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut microbiome impacting human health, today announces that Pierre Bélichard, CEO, will present an overview of the Company and take part in 1-on-1 meetings with institutional investors at the following conferences:
European Biotech Investor Days: April 7-8
Jefferies Microbiome-based therapeutics Summit: April 22
Jefferies Virtual Healthcare Conference: June 1-3
Enterome s CBO, Anne Dagallier, will participate and take part in 1-on-1 meetings with potential business partners at the following conferences:
Cabaletta Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Business Update marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.